Shantu Amin Selected Research

selenocyanic acid (selenocyanate)

10/2011	Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathway.
7/2006	Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shantu Amin Research Topics

Disease

94	Neoplasms (Cancer) 03/2022 - 01/2002
32	Carcinogenesis 01/2022 - 01/2002
17	Melanoma (Melanoma, Malignant) 03/2022 - 08/2006
16	Breast Neoplasms (Breast Cancer) 11/2021 - 07/2002
13	Lung Neoplasms (Lung Cancer) 11/2016 - 01/2003
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2021 - 08/2014
8	Adenocarcinoma 05/2021 - 07/2002
6	Mouth Neoplasms (Oral Cancer) 01/2022 - 08/2011
5	Leukemia 09/2021 - 03/2010
5	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2006
5	Inflammation (Inflammations) 01/2020 - 12/2010
5	Prostatic Neoplasms (Prostate Cancer) 10/2013 - 07/2009
5	Adenocarcinoma of Lung 10/2013 - 03/2006
4	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 03/2016
4	Necrosis 05/2021 - 12/2011
4	Colonic Neoplasms (Colon Cancer) 05/2016 - 11/2007
4	Carcinoma (Carcinomatosis) 05/2016 - 12/2006
3	Disease Progression 09/2021 - 01/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 07/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 03/2010
3	Squamous Cell Carcinoma of Head and Neck 01/2020 - 09/2013
3	Hepatocellular Carcinoma (Hepatoma) 03/2017 - 11/2002
3	Prostatic Intraepithelial Neoplasia 10/2013 - 03/2009
2	Leishmaniasis 01/2022 - 01/2019
2	Infections 01/2021 - 01/2020
2	Hepatomegaly 01/2021 - 01/2021
2	Multiple Myeloma 01/2020 - 01/2017
2	Oral Leukoplakia 01/2019 - 12/2017

Drug/Important Bio-Agent (IBA)

21	CarcinogensIBA 01/2021 - 01/2002
18	dibenzo(a,l)pyreneIBA 01/2022 - 12/2006
17	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2002
16	SeleniumIBA 02/2022 - 01/2003
12	SmokeIBA 01/2022 - 03/2006
12	DNA AdductsIBA 01/2022 - 11/2002
10	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021 - 04/2004
9	Pharmaceutical PreparationsIBA 01/2022 - 05/2008
8	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2022 - 03/2005
8	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 07/2002
7	LigandsIBA 06/2019 - 12/2007
6	Histone Deacetylase InhibitorsIBA 02/2022 - 05/2002
6	EnzymesIBA 02/2020 - 02/2002
6	Epoxy Compounds (Epoxides)IBA 01/2018 - 02/2003
5	Vorinostat FDA Link 02/2022 - 05/2002
5	IsothiocyanatesIBA 01/2019 - 01/2002
5	SulfurIBA 01/2019 - 03/2009
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2014 - 12/2007
5	sulforaphaneIBA 10/2013 - 03/2009
5	PPAR-betaIBA 07/2010 - 12/2007
5	1,4-phenylenebis(methylene)selenocyanateIBA 05/2009 - 01/2003
4	Phosphotransferases (Kinase)IBA 03/2022 - 01/2002
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
4	Biological ProductsIBA 01/2019 - 05/2016
4	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 07/2011
4	sphingosine kinaseIBA 07/2017 - 09/2010
4	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 09/2013 - 01/2003
4	Mitogen-Activated Protein KinasesIBA 01/2013 - 01/2002
3	CholesterolIBA 03/2022 - 04/2017
3	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2020
3	Antineoplastic Agents (Antineoplastics)IBA 11/2021 - 01/2013
3	SphingolipidsIBA 01/2020 - 07/2014
3	CytokinesIBA 01/2019 - 02/2010
3	pyreneIBA 01/2017 - 08/2010
3	marinopyrrole AIBA 08/2014 - 03/2012
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2013 - 05/2008
3	ISC-4 compoundIBA 01/2013 - 07/2011
3	Celecoxib (Celebrex)FDA Link 01/2013 - 07/2010
3	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 09/2010 - 12/2007
3	Tamoxifen FDA LinkGeneric 03/2009 - 10/2007
2	Benzo(a)pyreneIBA 01/2022 - 01/2002
2	Docosahexaenoic AcidsIBA 11/2021 - 02/2015
2	Dinoprostone (PGE2)FDA Link 11/2021 - 10/2014
2	4-oxo-5,7,10,13,16,19-docosahexaenoic acidIBA 11/2021 - 02/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2021 - 03/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021 - 07/2009
2	Caspase 3 (Caspase-3)IBA 05/2021 - 03/2016
2	GW 7647IBA 01/2021 - 01/2021
2	AldehydesIBA 02/2020 - 01/2020
2	Oxidoreductases (Dehydrogenase)IBA 02/2020 - 01/2020
2	Aldehyde DehydrogenaseIBA 01/2020 - 10/2013
2	Selenoproteins (Selenoprotein)IBA 01/2020 - 10/2014
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020 - 01/2017
2	Environmental CarcinogensIBA 01/2020 - 01/2017
2	CeramidesIBA 01/2020 - 12/2016
2	LipidsIBA 06/2019 - 09/2010
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 06/2019 - 07/2014
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019 - 01/2012
2	Urea (Carbamide)FDA LinkGeneric 01/2019 - 05/2016
2	NISC-6IBA 01/2019 - 07/2017
2	isoselenocyanateIBA 01/2019 - 07/2017
2	trans-1,2-dihydro-1,2-naphthalenediolIBA 12/2017 - 08/2011
2	NaphthalimidesIBA 07/2017 - 08/2011
2	selenoureaIBA 07/2017 - 05/2016
2	N'- ((1E)- 1- (3,4- dimethoxyphenyl)ethylidene)- 3- (4- methoxyphenyl)- 1H- pyrazole- 5- carbohydrazideIBA 07/2017 - 03/2015
2	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA 11/2016 - 08/2010
2	ThioureaIBA 05/2016 - 08/2011
2	Annexin A5IBA 03/2016 - 10/2012
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 03/2016 - 07/2012

Therapy/Procedure

16	Therapeutics 01/2022 - 10/2007
7	Chemoprevention 01/2019 - 10/2003
4	Drug Therapy (Chemotherapy) 01/2020 - 07/2010